

Cagrilintide
Cagrilintide research compound. Supplied as a lyophilized peptide for laboratory research applications.
For laboratory research use only. Not for human or veterinary use.
- Buy 2+ for $149.37 each and save 3%
- Buy 3+ for $146.29 each and save 5%
- Buy 5+ for $138.59 each and save 10%
- Buy 10+ for $130.89 each and save 15%
Direct from manufacturer to researcher
Shipping options confirmed at checkout
For laboratory research only

NEWAdvanced Laboratory Testing
Characteristics
| Molecular Formula | [C194H312N54O59S2](https://pubchem.ncbi.nlm.nih.gov/#query=C194H312N54O59S2) |
|---|---|
| CAS | 1415456-99-3 |
| Molar Mass | 4409 g/mol |
| Amino Acid Sequence | Lys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2 |
| Synonyms | AM833, NN9838, long-acting amylin analog (LAAA), amylin receptor agonist, modified human amylin analog, acylated amylin analog, investigational amylin mimetic |
| Solubility | Soluble in Water |
| Organoleptic Profile | White powder |
| Composition | Lyophilized powder - requires reconstitution |
How does Cagrilintide work?
Among the studied Cagrilintide peptide benefits, Cagrilintide's mechanism of action may primarily involve its role as a long-acting amylin analog that may interact with the calcitonin receptor. The peptide may demonstrate enhanced receptor activity compared to native amylin, with potentially improved pharmacokinetic properties. Research suggests that Cagrilintide may work through multiple pathways: 1. The primary mechanism may involve the activation of amylin receptors in key brain regions, particularly the area postrema and other circumventricular organs. This activation may lead to enhanced signaling and altered food intake through both direct and indirect neural pathways. 2. Additionally, studies indicate Cagrilintide peptides may have effects on gastric emptying and glucose metabolism. Research suggests it may influence gastric emptying rate and possibly affect postprandial glucose excursions, potentially contributing to observed laboratory measurements. 3. The peptide's potentially long half-life, which may be achieved through specific molecular modifications, may allow for sustained receptor activation, possibly leading to more consistent effects compared to shorter-acting analogs.
Handling & Safety
Handle as a laboratory research chemical of unknown hazard. Use gloves and eye protection, avoid inhalation of the lyophilized powder, and follow standard laboratory handling procedures. Reconstitute and store according to the product label. Lyophilized material should be kept cool, dry and protected from light; reconstituted material should be held at 2-8°C and protected from light. The safety profile of Cagrilintide has not been established. This compound is supplied for laboratory research use only and is not approved for human or veterinary use.
Summary
Cagrilintide may represent an advancement in amylin analog research, with Cagrilintide peptides receiving increasing attention in the field of metabolic research. Its modified structure may provide enhanced pharmacokinetic properties while potentially maintaining the receptor activity of amylin. Current research suggests there may be promising applications in areas related to metabolism, with ongoing studies exploring additional research potential. Research context only. No human or veterinary use.
Certificate of Analysis (COA)
Resource
All products on this site are for research and development use only. Products are not for human consumption of any kind. Neither the statements nor the products offered are intended to diagnose, treat, cure, or prevent any disease.
Peptide Research Insights
From the discoveries of 1977 to the next chapter in peptide science.
Explore research insights


